Emera Incorporated (EMA)
NYSE: EMA · Real-Time Price · USD
48.72
+0.65 (1.35%)
At close: Aug 8, 2025, 4:00 PM
47.60
-1.12 (-2.30%)
After-hours: Aug 8, 2025, 7:08 PM EDT

Intercept Pharmaceuticals Revenue

Emera had revenue of 1.99B CAD in the quarter ending June 30, 2025, with 22.94% growth. This brings the company's revenue in the last twelve months to 8.23B, up 12.00% year-over-year. In the year 2024, Emera had annual revenue of 7.20B, down -4.80%.

Revenue (ttm)
8.23B CAD
Revenue Growth
+12.00%
P/S Ratio
2.41
Revenue / Employee
1,082,051 CAD
Employees
7,605
Market Cap
14.57B USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20247.20B-363.00M-4.80%
Dec 31, 20237.56B-25.00M-0.33%
Dec 31, 20227.59B1.82B31.62%
Dec 31, 20215.77B259.00M4.70%
Dec 31, 20205.51B-605.00M-9.90%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition